Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations
International Journal of Cancer · 2025
DOI: 10.1002/ijc.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Huairen Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms, Multiple Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Biomedical Research Centre, VHL UK/Ireland, NIHR Cambridge Biomedical Research Centre.
Abstract (Originalsprache)
Multiple primary tumours (MPT) is a risk factor for an underlying predisposition to cancer. Renal cell carcinoma (RCC) occurs in several hereditary cancer disorder syndromes, and RCC‐related MPT comprise individuals with multiple primary renal tumours (MPRT) and those with RCC plus a non‐renal tumour (MPT:RCC + X). Excluding rare syndromic causes, knowledge of the genetic architecture of MPRT/MPT:RCC + X is limited. To inform diagnostic approaches to MPRT/MPT:RCC + X, we present the findings of comprehensive genomic analysis in 534 individuals. The presence/absence of variants in cancer susceptibility genes (CSGs) from exome/genome sequencing was then correlated with data on age, sex, tumour types, and RCC histopathology in 93 participants with MPRT and 441 with MPT:RCC + X. 7.5% of participants with MPRT and 6.1% in participants with MPT:RCC + X had germline CSG pathogenic variants, and the diagnostic yields increased to 9.4% and 10.4%, respectively, in cases with RCC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
- Manchester Centre for Genomic Medicine, and Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK.
- Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, UK.
ORCID-Profile: Eamonn R Maher
Förderung
- Manchester Biomedical Research Centre
- VHL UK/Ireland
- NIHR Cambridge Biomedical Research Centre
- Wellcome Trust
- Cancer Research UK Cambridge Cancer Centre
- NIH Oxford-Cambridge Scholars Program.
- Gates Cambridge Scholarship
- Medical Research Council
Zitieren
APA
Zhang, H., Yngvadottir, B., Andreou, A., Cole, Y., Woodward, E. R., Whitworth, J., & Maher, E. R. (2025). Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations. International Journal of Cancer. https://doi.org/10.1002/ijc.70085
Vancouver
Zhang H, Yngvadottir B, Andreou A, Cole Y, Woodward ER, Whitworth J, et al. Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations. International Journal of Cancer. 2025. doi:10.1002/ijc.70085
BibTeX
@article{Zhang2025,
author = {Zhang, Huairen and Yngvadottir, Bryndis and Andreou, Avgi and Cole, Yasemin and Woodward, Emma R and Whitworth, James and Maher, Eamonn R},
title = {Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.70085}
}
EUVIMED